Are IVV and XBI in the same category?

IVV is a stock ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.

Which returned more over the last year, IVV or XBI?

In the year to Oct 28, 2026, with distributions reinvested, IVV returned +13.7% and XBI +41.2%.

Which is cheaper, IVV or XBI?

IVV is cheaper, by 0.32 percentage points a year. That is about $32 on $10,000 held for a year. Fees come from each fund's prospectus.

How much do IVV and XBI overlap with the S&P 500?

By their latest filed holdings, 100% of IVV and 13% of XBI by weight is stocks the S&P 500 already holds.

Data as of Oct 28, 2026.

Across categories

IVV vs XBI: Differences, Returns & Fees

Share on X Download as PDF

Over the year to Oct 28, 2026, IVV returned +13.7% to XBI's +41.2%, and IVV charges 0.03% to XBI's 0.35%.

askIQ about this page

askIQ about IVV and XBI

Net assets on Oct 27, 2026: $885.1bn for iShares Core S&P 500 ETF and $10.3bn for State Street SPDR S&P Biotech ETF.

IVV on its own →XBI on its own →

At a glance

+13.7%

IVV total return, 1 year

+41.2%

XBI total return, 1 year

0.03%

IVV expense ratio

0.35%

XBI expense ratio

Pair scorecard

IVV costs 0.32 points a year less; their one-year returns differ by 27.5 points; IVV is far larger, $885.1bn against $10.3bn.

IVV vs XBI: Differences, Returns & Fees
Measure	IVV	XBI
Return
Measure	IVV	XBI
Total return, 1 year	+13.7%	+41.2%
Drawdown
Measure	IVV	XBI
Below its all-time high		8.9%, high on Feb 8, 2021
Benchmark
Measure	IVV	XBI
What it tracks	S&P 500	Biotech
Cost and size
Measure	IVV	XBI
Expense ratio	0.03%	0.35%
Net assets, as of Oct 27, 2026	$885.1bn	$10.3bn
Active share vs the S&P 500		98%
Holdings
Measure	IVV	XBI
Holdings in common	2%
Top ten holdings, share of the fund	38.1%	18%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

By the books each fund has filed, IVV and XBI hold 2% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

50%

0 half 100%

half

2% in common

Positions both hold · largest shared weight first IVV XBI

ABBVIE 0.76% 1.67%

AMGEN INC 0.36% 1.68%

GILEAD SCIENCES 0.30% 1.60%

VERTEX PHARMACEUTICALS 0.20% 1.46%

REGENERON PHARMACEUTICALS 0.12% 1.48%

MODERNA 0.12% 2.24%

BIOGEN 0.06% 1.75%

INCYTE CORP 0.03% 1.35%

Only in one fund ↓

Only in IVV

NVIDIA 7.92%

APPLE 7.61%

MICROSOFT 5.93%

AMAZON.COM INC 3.73%

ALPHABET CLASS A 2.83%

BROADCOM INC 2.45%

ALPHABET CLASS C 2.26%

META PLATFORMS CLASS A 2.05%

Only in XBI

TWIST BIOSCIENCE CORP 1.86%

NATERA INC 1.82%

HALOZYME THERAPEUTICS INC 1.75%

UNITED THERAPEUTICS CORP 1.71%

SPYRE THERAPEUTICS INC 1.67%

EXELIXIS INC 1.64%

IOVANCE BIOTHERAPEUTICS INC 1.62%

ORUKA THERAPEUTICS INC 1.53%

Check overlap with more funds →

Side by side

IVV iShares Core S&P 500 ETF XBI State Street SPDR S&P Biotech ETF

Where it sits Stock ETF Thematic ETF

Issuer iShares State Street

What it is Tracks the S&P 500 Biotech

Total return, 1 year +13.7% +41.2%

Its benchmark over the same days +13.6% (SPY) not measured

Gap to its benchmark +0.1 pts vs SPY not measured

Expense ratio 0.03% 0.35%

Already in the S&P 500 99.8% 13.2%

Holdings 505 165

Net assets, as of Oct 27, 2026 $885.1bn $10.3bn

IVV and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

About each fund

IVV

IVV tracks the S&P 500. Over the year to Oct 28, 2026 it returned +13.7% with distributions reinvested, against +13.6% for its benchmark, the S&P 500. The prospectus expense ratio is 0.03% a year. By its holdings published by its issuer for Oct 27, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 505 positions, with the top ten at 38.1%.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are IVV and XBI in the same category?: IVV is a stock ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, IVV or XBI?: In the year to Oct 28, 2026, with distributions reinvested, IVV returned +13.7% and XBI +41.2%.
Which is cheaper, IVV or XBI?: IVV is cheaper, by 0.32 percentage points a year. That is about $32 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do IVV and XBI overlap with the S&P 500?: By their latest filed holdings, 100% of IVV and 13% of XBI by weight is stocks the S&P 500 already holds.

Other comparisons

IBB vs IVV IVV vs URA IVV vs KWEB IVV vs XT GRNY vs XBI SPY vs XBI SPYM vs XBI VIG vs XBI

Where to next

IVV on its own →XBI on its own →Hold both: look the portfolio through →Rankings →IVV dividend history →IVV holdings →XBI dividend history →XBI holdings →Standards and sources →

Sources and dates

IVV filings on SEC EDGAR ↗

IVV prospectus with the expense ratio (SEC) ↗

iShares page for IVV ↗

XBI filings on SEC EDGAR ↗

XBI prospectus with the expense ratio (SEC) ↗

State Street website ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Cite this pageCitation, APA and Markdown

ETFIQ, IVV against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/ivv-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.